| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.61▲ | 9.66▼ | 9.62▼ | 9.56▲ | 9.38▲ |
| MA10 | 9.62▼ | 9.61▼ | 9.66▼ | 9.54▲ | 9.24▲ |
| MA20 | 9.65▼ | 9.68▼ | 9.61▼ | 9.32▲ | 9.26▲ |
| MA50 | 9.60▲ | 9.59▲ | 9.52▲ | 9.16▲ | 9.69▼ |
| MA100 | 9.66▼ | 9.53▲ | 9.36▲ | 9.39▲ | 10.02▼ |
| MA200 | 9.60▲ | 9.35▲ | 9.38▲ | 9.59▲ | 12.01▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.011▼ | -0.004▼ | -0.012▼ | 0.037▲ | 0.074▲ |
| RSI | 46.141▼ | 49.016▼ | 50.932▲ | 54.859▲ | 51.761▲ |
| STOCH | 19.524▼ | 75.782 | 41.108 | 47.227 | 50.269 |
| WILL %R | -82.353▼ | -52.941 | -57.143 | -38.579 | -37.900 |
| CCI | -68.096 | 12.819 | -29.718 | 49.588 | 104.579▲ |
|
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Tuesday, May 14, 2024 10:25 PM
YUPELRI® (revefenacin) net sales of $55.2 million, recognized by Viatris, increased 18% from Q1 20231 Viatris collaboration revenue of $14.5 million, increased 39% versus Q1 2023, reflecting ...
|
|
Tuesday, May 14, 2024 09:00 PM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
|
|
Tuesday, May 14, 2024 05:00 PM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/05/24 | 9.59 | 9.75 | 9.37 | 9.61 | 366,027 |
| 15/05/24 | 9.52 | 9.93 | 9.41 | 9.85 | 285,699 |
| 14/05/24 | 9.74 | 9.99 | 9.32 | 9.39 | 301,145 |
| 13/05/24 | 9.52 | 9.58 | 9.395 | 9.565 | 185,630 |
| 10/05/24 | 9.45 | 9.60 | 9.25 | 9.38 | 339,462 |
| 09/05/24 | 9.50 | 9.63 | 9.32 | 9.47 | 282,326 |
| 08/05/24 | 9.50 | 9.63 | 9.41 | 9.49 | 298,624 |
| 07/05/24 | 9.62 | 9.72 | 9.42 | 9.54 | 369,855 |
| 06/05/24 | 9.87 | 10.37 | 9.58 | 9.60 | 539,000 |
| 03/05/24 | 9.48 | 9.625 | 9.29 | 9.46 | 334,008 |
|
|
||||
|
|
||||
|
|